Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy-Reference-Cited by-同舟云学术

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

Published:2012-09-18 Issue:3 Volume:62 Page:471-479
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Yao Yanwen,Yuan Dongmei,Liu Hongbing,Gu Xiaoling,Song Yong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-012-1347-9.pdf

Reference27 articles.

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

2. Gu X, Ma C, Yuan D et al (2012) Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review. Transl Lung Cancer Res 1:36–44

3. Tanner NT, Sherman CA, Silvestri GA (2012) Biomarkers in the selection of maintenance therapy in nonsmall cell lung cancer. Transl Lung Cancer Res 1:96–98

4. Donnem T, Bremnes RM, Busund LT et al (2012) Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. J Thorac Dis 4:212–213

5. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy;The Clinical Respiratory Journal;2024-04-29

2. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer;Asia-Pacific Journal of Clinical Oncology;2024-04-04

3. Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer;Scientific Reports;2024-01-03

4. Predictors of Response to Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Prospective Cohort Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

5. Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) in advanced-stage lung cancer;Journal of Cancer Research and Therapeutics;2023-12-15